| Literature DB >> 31500116 |
Justina Paulauskiene1, Rugile Ivanauskiene2, Erika Skrodeniene3, Janina Petkeviciene4.
Abstract
Background andEntities:
Keywords: Lithuania; barriers; cervical cancer; non-attendance; place of residence; screening
Mesh:
Year: 2019 PMID: 31500116 PMCID: PMC6780374 DOI: 10.3390/medicina55090570
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1The proportion of invited, non-invited and screened women before the study, after the first personal invitation letter and after reminder letter in urban and rural primary health care centres (PHCC). a p values < 0.001 compared with the coverage of cervical cancer (CC) screening before the study; b p values < 0.001 compared with the coverage of CC screening in Kaunas.
The participation of women in CC screening by age and the Pap smear test results after the first invitation and reminder letters in urban and rural PHCCs.
| Urban PHCC | Rural PHCC | |||||||
|---|---|---|---|---|---|---|---|---|
| The First Invitation Letter | The Reminder Letter | The First Invitation Letter | The Reminder Letter | |||||
| Invited | Attended | Invited | Attended | Invited | Attended | Invited | Attended | |
| N | N (%) | N | N (%) | N | N (%) | N | N (%) | |
|
| ||||||||
| 25–34 | 350 | 66 (18.9) * | 245 | 48 (19.6) | 428 | 99 (23.1) * | 221 | 47 (21.3) |
| 35–44 | 438 | 124 (28.3) | 281 | 47 (16.7) | 401 | 143 (35.7) | 194 | 54 (27.8) |
| 45–54 | 546 | 129 (23.6) | 382 | 61 (16.0) | 619 | 202 (32.6) | 328 | 72 (22.0) |
| 55–60 | 257 | 72 (28.0) | 134 | 20 (14.9) | 395 | 123 (31.1) | 186 | 33 (17.7) |
| Total | 1591 | 391 (24.6) | 1042 | 176 (16.9) | 1843 | 567 (30.8) ** | 929 | 206 (22.2) |
|
| ||||||||
| Unknown result a | 20 (5.1) | 4 (2.2) | 34 (6.0) | 5 (2.4) | ||||
| Normal | 270 (69.1) | 133 (75.6) | 353 (62.3) | 152 (73.8) | ||||
| Abnormal b | 101 (25.8) | 39 (22.2) | 180 (31.7) *** | 49 (23.8) | ||||
a The Pap smear has been taken but the cytologic test results are unknown; b Epithelial cell abnormalities: atypical squamous cells (ASC), low grade squamous intraepithelial lesion (LSIL), high grade squamous intraepithelial lesion (HSIL), atypical glandular cell (AGS). * p < 0.05 compared with women aged 35–44 and 55–60 in the urban PHCC and women aged 35–44 and 45–54 in the rural PHCC; ** p < 0.001 compared with urban women; *** p < 0.05 compared with the percentage of abnormal Pap smear tests in the urban PHCC and after a reminder letter in the rural PHCC.
The odds ratios of participation in CC screening and abnormal Pap smear test results after two systematic invitation letters by study area and age (multivariate logistic regression analysis).
| Variable | Participation Rate | Abnormal Pap Smear Tests | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| The First Invitation Letter | The Reminder Letter | The First Invitation Letter | The Reminder Letter | |||||||||
| OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
|
| ||||||||||||
| Urban | 1 | 1 | 1 | 1 | ||||||||
| Rural | 1.39 | 1.19–1.61 | <0.001 | 1.44 | 1.15–1.80 | 0.002 | 1.39 | 1.04–1.85 | 0.027 | 1.10 | 0.68–1.78 | 0.710 |
|
| ||||||||||||
| 25–34 | 1 | 1 | 1 | 1 | ||||||||
| 35–44 | 1.78 | 1.42–2.23 | <0.001 | 1.08 | 0.79–1.48 | 0.630 | 1.40 | 0.92–2.13 | 0.117 | 1.59 | 0.80–3.16 | 0.190 |
| 45–54 | 1.49 | 1.20–1.84 | <0.001 | 0.90 | 0.67–1.21 | 0.501 | 0.91 | 0.60–1.37 | 0.644 | 1.63 | 0.85–3.13 | 0.141 |
| 55–60 | 1.56 | 1.23–1.99 | <0.001 | 0.75 | 1.15–1.80 | 0.122 | 0.77 | 0.48–1.23 | 0.266 | 1.06 | 0.44–2.51 | 0.904 |
The effect of systematic personal invitation letters on coverage of cervical cancer screening in urban and rural PHCCs.
| Coverage of Cervical Cancer Screening | |||
|---|---|---|---|
| N | % (95% CI) | Increase % | |
|
| |||
| Before the study (invitation by a family doctor) | 169 | 9.6 (8.2–11.0) | - |
| 1st invitation letter | 560 | 31.8 (29.6–34.0) | +231.3 |
| 2nd invitation letter | 736 | 41.8 (39.5–44.1) | +31.4 |
| Total increase | +335.4 | ||
|
| |||
| Before the study (invitation by a family doctor) | 317 | 14.7 (13.2–16.2) | - |
| 1st invitation letter | 884 | 40.9 (39.9–42.0) | +178.2 |
| 2nd invitation letter | 1090 | 50.5 (49.4–51.5) | +23.5 |
| Total increase | +243.5 | ||
Barriers for nonattendance in a cervical cancer screening programme in urban and rural PHCCs: the phone interview.
| Urban PHCC ( | Rural PHCC ( | |
|---|---|---|
|
|
|
|
| Intends to attend for a Pap smear test but faces various obstacles | 52.7 | 36.1 |
| Worries that a Pap smear test might be unpleasant | 34.6 | 36.8 |
| Believes that she is not at risk of cervical cancer | 21.2 | 25.0 |
| Is afraid to be diagnosed with cervical cancer | 20.8 | 27.8 |
| Negative experience during a Pap test in the past | 20.0 | 8.3 |
| Feels healthy and sees no need for a Pap test | 15.4 | 22.2 |
| Sexually inactive for a long time and sees no need to attend | 15.1 | 16.2 |
| Doesn’t trust the efficiency of a Pap test | 9.3 | 13.5 |
|
|
|
|
| The long waiting-time for doctor’s appointment | 49.1 | 34.3 |
| Lack of time due to long working hours or family duties | 41.5 | 29.7 |
| Has a regular gynaecological examination | 24.5 | 24.3 |
| Inconvenient appointment time | 23.6 | 10.8 |
| A family doctor doesn’t invite to participate in the screening | 11.3 | 24.3 |
| Has never heard of a Pap test | 7.5 | 16.2 |
| Has never been invited to have a Pap test | 7.5 | 22.2 |
| The clinic is too far away from women’s living place | 1.9 | 22.2 |